Rivastigmine and Convulsion - a phase IV clinical study of FDA data

Summary:

Convulsion is reported as a side effect among people who take Rivastigmine (rivastigmine tartrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Omeprazole, and have Dementia alzheimer's type.

The phase IV clinical study analyzes which people have Convulsion when taking Rivastigmine. It is created by eHealthMe based on reports of 7,475 people who have side effects when taking Rivastigmine from the FDA, and is updated regularly.

What is Rivastigmine?

Rivastigmine has active ingredients of rivastigmine tartrate. It is often used in dementia. eHealthMe is studying from 7,517 Rivastigmine users. Check the latest studies of Rivastigmine.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,843 drugs and 2,858 conditions by eHealthMe. Check the latest studies of Convulsion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

7,475 people reported to have side effects when taking Rivastigmine.
Among them, 19 people (0.25%) have Convulsion.

Among these 19 people:

How long have people been on Rivastigmine when they have Convulsion? *

What is the gender of people who have Convulsion when taking Rivastigmine? *

female: 36.84 %
male: 63.16 %

What is the age of people who have Convulsion when taking Rivastigmine? *

What are other drugs people take besides Rivastigmine? *

What are other side effects people have besides Convulsion? *

Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 5 people, 26.32%
Drowsiness: 3 people, 15.79%
Taciturnity (the state or quality of being reserved or reticent in conversation): 3 people, 15.79%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 3 people, 15.79%
Hypophagia (reduced food intake): 2 people, 10.53%
Anticonvulsant Drug Level Decreased: 2 people, 10.53%
Gait Disturbance: 2 people, 10.53%
Hemiplegia (paralysis of one side of the body): 1 person, 5.26%
Drug Level Decreased: 1 person, 5.26%
Drug Level Below Therapeutic: 1 person, 5.26%

What are the existing conditions these people have? *

Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 9 people, 47.37%
Depression: 3 people, 15.79%
Urinary Tract Infection: 2 people, 10.53%
Psychotic Disorder: 2 people, 10.53%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 10.53%
Gastritis (inflammation of stomach): 1 person, 5.26%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 5.26%
Diabetes: 1 person, 5.26%
Duodenitis (inflammation of the duodenum): 1 person, 5.26%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Rivastigmine and have Convulsion?

- Check whether Convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivastigmine:

Rivastigmine (7,517 reports)

Convulsion treatments and more:

Convulsion (99,535 reports)

Browse all side effects of Rivastigmine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Convulsion:

Convulsion (1,843 drugs)

Browse all the conditions that are associated with Convulsion:

Convulsion (2,858 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Rivastigmine) and Rivastigmine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.